• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Livongo buys diabetes management company Diabeto

September 14, 2017 By Sarah Faulkner

livongo, diabetoLivongo Health said yesterday that it bought digital diabetes management company, Diabeto, for an undisclosed amount.

Diabeto sells a connectivity technology called Birdie that plugs into more than 40 different glucose meters, connecting them to Diabeto’s mobile apps and to Livongo’s newly-released apps.

“We’ve heard from the market that, in addition to a comprehensive solution like Livongo, they also wanted options for their people with diabetes who wanted to keep their existing glucose meter,” Livongo CEO Glen Tullman said in prepared remarks. “They told us existing connectivity solutions in the market were too expensive and ineffective. We plan to price the Diabeto at less than half of what those solutions sell for today, making this option much more affordable. We believe Diabeto will enhance what is already the most comprehensive and effective diabetes care management solution on the market today.”

The company said that its partnership with Diabeto will allow it to capture data from other glucose meters and make it more convenient for doctors to treat patients with Type II diabetes.

“If we want to really make life easier for people with diabetes, we have to reduce the hassles they face and make it less expensive for everyone to share information, which is the first step in getting better care,” Diabeto CEO Shreekant Pawar added. “We’re excited to bring our connectivity solution and our customers into the Livongo family.”

See the best minds in medtech live at DeviceTalks Boston on Oct. 2. 

Filed Under: Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Pharmaceuticals, Wall Street Beat Tagged With: diabeto, livongohealth

IN CASE YOU MISSED IT

  • Medtronic to separate Diabetes business unit
  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS